Maleen Fischer, whose “blue lips” in infancy were dismissed by doctors for nearly four years before receiving a diagnosis of pulmonary arterial hypertension at age four. In a recent article for Cambridge Network News and in a blog for electronRx she shares how despite years on continuous IV medication and isolation during childhood and adolescence, she adapted to her condition by pursuing creative writing rather than physically demanding activities, eventually studying at Harvard and becoming an advocate for others with the same condition. Maleen emphasises that knowing the boundaries of her health allowed her to adjust her life around her dreams rather than letting her condition dictate them.
The article highlights the challenges of diagnostic delays with pulmonary arterial hypertension and proposes solutions, including the need for a collaborative, multi-disciplinary approach among general practitioners, cardiologists, pulmonologists, and advanced care specialists can help break down the silos of specialty care that delay diagnosis. She also says mobile health platforms can enable patients to monitor their condition remotely, track health metrics, and communicate more effectively with healthcare providers. This combination of patient advocacy, proactive healthcare, and digital tools aims to transform pulmonary arterial hypertension management from reactive to proactive, ultimately improving patients’ quality of life.
Read more at this link on Cambridge Network News
